Works matching IS 00912700 AND DT 2009 AND VI 49 AND IP 7


Results: 16
    1
    2
    3
    4

    Single-Dose Administration of MK-0657, an NR2B-Selective NMDA Antagonist, Does Not Result in Clinically Meaningful Improvement in Motor Function in Patients With Moderate Parkinson's Disease.

    Published in:
    Journal of Clinical Pharmacology, 2009, v. 49, n. 7, p. 856, doi. 10.1177/0091270009336735
    By:
    • Addy, Carol;
    • Assaid, Chris;
    • Hreniuk, David;
    • Stroh, Mark;
    • Yang Xu;
    • Herring, W. Joseph;
    • Ellenbogen, Aaron;
    • Jinnah, H. A.;
    • Kirby, Louis;
    • Leibowitz, Mark T.;
    • Stewart, R. Malcolm;
    • Tarsy, Daniel;
    • Tetrud, James;
    • Stoch, S. Aubrey;
    • Gottesdiener, Keith;
    • Wagner, John
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16